• Western Secondary Antibody Dilution Buffer Guide

  2026-09-04

  Western Secondary Antibody Dilution Buffer K4115 is formulated to support consistent secondary-antibody dilution, reduce non-specific antibody binding, and improve antibody stability in assays. Its product-reported reuse, storage, and volume specifications can help standardize protein detection Western blot workflows without changing the underlying biology measured.

• Arachidonic Acid for Immune Assay Workflows

  2026-09-04

  A practical guide to using Arachidonic Acid as a controllable substrate for immune, inflammation, and eicosanoid-biosynthesis experiments. The workflow emphasizes solvent control, oxidation management, pathway-resolved readouts, and translation of recent vaccine-immunity findings into bench assays.

• Amyloid Beta-Peptide (1-40): Assay Workflows

  2026-09-03

  Build more reproducible Alzheimer’s disease experiments by controlling Aβ40 concentration, assembly state, storage, and exposure time. This workflow positions the peptide for parallel fibril-formation, neuronal toxicity, calcium-signaling, and microglial immune-regulation assays.

• Lenalidomide (CC-5013) in Myeloma Research

  2026-09-03

  Lenalidomide (CC-5013) combines immune remodeling, TNF-alpha suppression, and anti-angiogenic activity in versatile hematologic cancer assays. This workflow shows how to test its multiple myeloma activity alone or alongside DOT1L inhibition while preserving solvent control, mechanistic readouts, and reproducibility.

• Abiraterone Acetate in Patient-Derived 3D Models

  2026-09-02

  Discover how Abiraterone acetate can be evaluated as a CYP17 inhibitor in patient-derived prostate spheroids. This evidence-led guide connects steroid biology, model quality, and assay interpretation while distinguishing organ-confined disease models from CRPC research.

• Lanabecestat (AZD3293) Assay Workflow

  2026-09-02

  A scenario-based guide to using Lanabecestat (AZD3293), SKU BA8438, in Alzheimer’s disease research and cell-based viability, proliferation, and cytotoxicity workflows. It connects BACE1 potency, amyloid-beta measurements, vehicle controls, synaptic-function assays, and practical product-selection decisions to improve interpretation and reproducibility.

• iPSC Organoids Reveal Pan-Tissue HEV Infection

  2026-09-01

  This reference study establishes multilineage iPSC-derived liver, intestinal and brain organoids that support complete propagation of wild-type HEV genotypes 1, 3 and 4. The models resolve tissue-specific viral tropism, injury responses and partial ribavirin rescue, offering a physiologically relevant platform for host–pathogen research and antiviral evaluation.

• T0070907 as a PPARγ Pathway Counterprobe

  2026-09-01

  T0070907 is a high-affinity PPARγ antagonist for separating receptor-dependent transcription from broader cellular effects. This article shows how to apply it as a mechanistic counterprobe when studying the RXRα/PPARγ/NEDD4 axis and SASP-associated inflammation.

• Mitochondrial Repair in Diabetic Periodontitis

  2026-08-31

  The reference study develops a hierarchically targeted, ROS-responsive hydrogel platform designed to repair mitochondrial dysfunction in M1 macrophages during diabetic periodontitis. By combining tuftsin-functionalized MitoQ-loaded nanoparticles with a ROS-cleavable PVA hydrogel, the approach suppresses inflammasome-associated inflammation and improves periodontal bone regeneration in a diabetic rat model.

• Fludarabine in Neoantigen Immunotherapy Workflows

  2026-08-31

  Learn how Fludarabine can support controlled DNA-damage, cell-cycle, and apoptosis studies while informing lymphodepletion-inspired immunotherapy experiments. This workflow-focused guide connects leukemia and multiple myeloma models with practical antigen-presentation and T-cell co-culture assays.

• Protease Inhibitor Cocktail: Practical Use Guide

  2026-08-30

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic damage during protein extraction and downstream analysis, including Western blotting, co-immunoprecipitation, and phosphorylation-sensitive assays. Its EDTA-free composition is useful when divalent cations must remain available, but protocols that depend on EDTA, are sensitive to DMSO, or require uninhibited enzyme activity need separate compatibility testing.

• MTT Assay Workflow for Resistant Cancer Cells

  2026-08-29

  Build a reproducible MTT workflow for measuring viability, proliferation, and treatment response in adherent cancer models. The approach links practical formazan chemistry with the HDAC8–AKT resistance biology reported in HT-29 and B16-BL6 cells, while emphasizing controls for metabolic confounding and optical interference.

• Cy7 NHS Ester: Practical Labeling Guide

  2026-08-28

  Cy7 NHS ester (SKU A8109) is a water-soluble near-infrared protein labeling dye for attaching a Cy7 fluorophore to accessible amino groups on proteins and peptides. It is suited to aqueous labeling and near-infrared fluorescent imaging, but it should not be selected for targets without accessible primary amines or workflows requiring long-term storage of prepared dye solutions.

• Streptavidin – FITC: Reliable Biotin Detection

  2026-08-28

  This scenario-based guide explains how Streptavidin – FITC (SKU K1081) can improve fluorescent detection of biotinylated antibodies, proteins, and nucleic acids in cell-based and tissue assays. It connects defined binding and optical specifications with practical controls, storage, interpretation, and vendor-selection decisions.

• Amphotericin B: From Sterol Binding to Translation

  2026-08-27

  A mechanistic and translational framework for using Amphotericin B as a benchmark in fungal infection research, linking fungal membrane sterol interaction, orthogonal assay design, innate immune signaling, and preclinical model interpretation.

7853 records 1/524 page Next 12345 下5页 Last page